IP Library Granted Patent US 8,927,736
Granted Patent B2
US 8,927,736 · App. 13/389,987 · Granted Jan 6, 2015

Copper catalyzed cycloaddition of organic azides and 1-haloalkynes

Inventors: Jason E. Hein (La Jolla, CA); Jonathan C. Tripp (Westfield, NJ); Larissa Krasnova (San Diego, CA); K. Barry Sharpless (La Jolla, CA); Valery V. Fokin (Oceanside, CA)
Assignee: The Scripps Research Institute
B01J31/1805B01J23/72B01J31/181C07D249/06C07D311/12C07D405/04B01J2531/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,736
App. No.
13/389,987
Granted
Jan 6, 2015
Kind
B2
Abstract

This invention provides a method for preparing a 1,2,3-triazole compound comprising contacting an organic azide with a 2-substituted-1-haloalkyne, in the presence of a copper catalyst and a copper-coordinating ligand (preferably a tertiary amine) in a liquid reaction medium, thereby forming a 1,4,5-substituted-1,2,3-triazole compound including a halo substituent at the 5-position of the triazole, the organic portion of the organic azide at the 1-position of the triazole, and the substituent of the 1-iodoalkyne at the 4-position of the triazole. A method for preparing 1-iodoalkynes is also provided.

Claims (28)

1. A method for preparing a 1,2,3-triazole compound comprising contacting an organic azide with a 2-substituted-1-iodoalkyne in the presence of a copper catalyst and an copper-coordinating ligand in a liquid reaction medium, thereby forming a 1,4,5-substituted-1,2,3-triazole compound including a iodo substituent at the 5-position of the triazole, the organic portion of the organic azide at the 1-position of the triazole, and the substituent of the 1-iodoalkyne at the 4-position of the triazole; wherein the copper-coordinating ligand comprises one or more materials selected from the group consisting of an amine, a thiol or salt thereof, a sulfide, a disulfide, a thiophene, a thiazole, and a phosphine.

2. The method of claim 1 wherein the copper catalyst comprises a Cu(I) salt.

3. The method of claim 1 wherein the copper catalyst comprises cuprous iodide.

4. The method of claim 1 wherein the copper catalyst or a portion thereof is generated in situ by reduction of a Cu(II) salt.

5. The method of claim 1 wherein the copper catalyst or a portion thereof is generated in situ by oxidation of Cu(0).

6. The method of claim 1 wherein the copper-coordinating ligand comprises a tertiary amine ligand.

7. The method of claim 1 wherein the copper-coordinating ligand comprises a 1,2,3-triazole-substituted tertiary amine.

8. The method of claim 1 wherein the copper-coordinating ligand comprises triethylamine.

9. The method of claim 1 wherein the copper-coordinating ligand comprises tris((1-tert-butyl-1H-1,2,3-triazolyl)methyl)amine (TTTA) or tris((1-benzyl-1H-1,2,3-triazolyl)methyl)amine (TBTA).

10. The method of claim 1 wherein the liquid reaction medium comprises an aprotic organic solvent.

11. The method of claim 10 wherein the aprotic organic solvent comprises at least one liquid selected from the group consisting of an ether, an amide, a nitrile, a hydrocarbon, and a chlorinated hydrocarbon.

12. The method of claim 1 wherein the liquid reaction medium comprises an alcohol.

13. The method of claim 1 wherein the liquid reaction medium comprises water.

14. The method of claim 1 wherein the organic azide is contacted with at least a stoichiometric amount of the 1-iodoalkyne based on the molar amount of azide in the organic azide and the molar amount of alkyne in the 1-iodoalkyne.

15. The method of claim 1 wherein the organic azide is contacted with less than a stoichiometric amount of the 1-iodoalkyne based on the molar amount of azide in the organic azide and the molar amount of alkyne in the 1-iodoalkyne.

16. The method of claim 1 wherein the organic azide is contacted with greater than a stoichiometric amount of the 1-iodoalkyne based on the molar amount of azide in the organic azide and the molar amount of alkyne in the 1-iodoalkyne.

17. The method of claim 1 including the additional step of separating the 1,4,5-substituted-1,2,3-triazole compound from the copper-coordinating ligand and any copper-containing materials present.

18. The method of claim 1 including the additional step of isolating the 1,4,5-substituted-1,2,3-triazole compound from the liquid reaction medium.

19. The method of claim 1 including the additional step of contacting the 1,4,5-substituted-1,2,3-triazole compound with an arylboronic acid in the presence of a Pd(0) catalyst, thereby replacing the 5-iodo substituent of the triazole with the aryl portion of the arylboronic acid.

20. The method of claim 1 including the additional step of contacting the 1,4,5-substituted-1,2,3-triazole compound with a reducing agent to replace the 5-iodo substituent with a hydrogen.

21. The method of claim 1 wherein the organic azide comprises a polyethylene glycol substituent and the substituent of the 2-substituted-1-iodoalkyne comprises a protein.

22. The method of claim 1 wherein the organic azide comprises a protein substituent and the substituent of the 2-substituted-1-iodoalkyne comprises a polyethylene glycol group.

23. The method of claim 1 wherein the liquid reaction medium includes a reducing agent.

24. The method of claim 23 wherein the reducing agent comprises a thiol compound.

25. The method of claim 24 wherein the thiol compound comprises dithiothreitol (DTT).

26. The method of claim 1 wherein the liquid reaction medium includes a surfactant.

27. The method of claim 26 wherein the surfactant comprises sodium docecyl sulfate.

28. The method of claim 1 wherein the 1,4,5-substituted-1,2,3-triazole compound is represented by the formula

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 11, 2015
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037277/0183 →
CONFIRMATORY LICENSE Recorded Sep 28, 2012
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029050/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2012
From: HEIN, JASON E.; TRIPP, JONATHAN C.; KRASNOVA, LARISSA; SHARPLESS, K. BARRY; FOKIN, VALERY V.
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 027875/0640 →
Continuity (2)
Provisional Application 61273939 · Aug 11, 2009
Related Publication 20120142935A1 · Jun 7, 2012